Hypokalemia medical therapy: Difference between revisions
Jump to navigation
Jump to search
| Line 31: | Line 31: | ||
* When replacing potassium intravenously, infusion via central line is encouraged to avoid the frequent occurrence of a burning sensation at the site of a peripheral IV and the aforementioned venous necrosis. When peripheral infusions are necessary, the burning can be reduced by diluting the potassium in larger amounts of IV fluid, or mixing 3 ml of 1% [[lidocaine]] to each 10 meq of KCl per 50 ml of IV fluid. The practice of adding lidocaine, however, raises the likelihood of serious medical errors.<ref name="urlSafety Issues With Adding Lidocaine to IV Potassium Infustions (Excerpt)">{{cite web |url=http://www.ismp.org/newsletters/acutecare/articles/20040212_2.asp |title=Safety Issues With Adding Lidocaine to IV Potassium Infustions (Excerpt) |format= |work= |accessdate=2013-02-27}}</ref> | * When replacing potassium intravenously, infusion via central line is encouraged to avoid the frequent occurrence of a burning sensation at the site of a peripheral IV and the aforementioned venous necrosis. When peripheral infusions are necessary, the burning can be reduced by diluting the potassium in larger amounts of IV fluid, or mixing 3 ml of 1% [[lidocaine]] to each 10 meq of KCl per 50 ml of IV fluid. The practice of adding lidocaine, however, raises the likelihood of serious medical errors.<ref name="urlSafety Issues With Adding Lidocaine to IV Potassium Infustions (Excerpt)">{{cite web |url=http://www.ismp.org/newsletters/acutecare/articles/20040212_2.asp |title=Safety Issues With Adding Lidocaine to IV Potassium Infustions (Excerpt) |format= |work= |accessdate=2013-02-27}}</ref> | ||
* Potassium infusions via a central line can reach 200 mEq/L (20 mEq in 100 mL of isotonic saline) but the administration rate should not be greater than 10–20 mEq per hour. | * Potassium infusions via a central line can reach 200 mEq/L (20 mEq in 100 mL of isotonic saline) but the administration rate should not be greater than 10–20 mEq per hour. | ||
* Saline solutions are preferred to prevent potassium transcellular shifting that is triggered by dextrose-induced insulin release | * Saline solutions are preferred to prevent potassium transcellular shifting that is triggered by dextrose-induced insulin release. | ||
==References== | ==References== | ||
Revision as of 14:44, 27 February 2013
|
Hypokalemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hypokalemia medical therapy On the Web |
|
American Roentgen Ray Society Images of Hypokalemia medical therapy |
|
Risk calculators and risk factors for Hypokalemia medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Assistant Editor(s)-In-Chief: Jack Khouri
Overview
The oral route is the safest. There are many oral potassium salts that can be prescribed including potassium chloride KCl (the most popular) and the organic alkalinizing salts that are metabolized to potassium bicarbonate KHCO3 in the body. Severe hypokalemia ca be treated via IV KCl infusion with doses that shouldn't exceed 60 mEq/L unless ECG monitoring is provided. A central line can be used for administration of greater concentrations of KCl.
Medical Therapy
The most important step in severe hypokalemia is removing the cause, such as treating diarrhea or stopping offending medication.
- Patients treated with loop or thiazide diuretics can be offered medications that counteract their kaliuretic effect such as aldosterone antagonists (spironolactone and eplerenone) or distal sodium channel blockers (eg, amiloride).
- The combination of thiazide and loop diuretics should be avoided.
- Oral potassium administration is safer than the IV route.
- An oral dose should not exceed 20-40 mEq.
- IV potassium infusion should be reserved for symptomatic patients with severe hyperkalemia and patients who can't take oral supplements.
Mild Hypokalemia
- Potassium levels in the range 3.0-3.5 mEq/L.
- Represent potassium deficit of 200-400 mEq.
- May be treated with oral potassium salt supplements: potassium chloride KCl (Sando-K®, Slow-K®) or potassium bicarbonate KHCO3 (which can be generated from the metabolism of many organic salts eg, potassium citrate, potassium gluconate, etc).
- Potassium-containing foods may be recommended, such as tomatoes, oranges or bananas, but they are less effective than oral supplements.
- Both dietary and pharmaceutical supplements are used for people taking diuretic medications.
- KCl is the most effective replacement for metabolic alkalosis-associated hypokalemia.
- KHCO3 and the organic "alkalinizing" salts potassium citrate and potassium gluconate are recommended for hypokalemia associated with metabolic acidosis (chronic diarrhea, renal tubular acidosis,etc).
Severe Hypokalemia
- Potassium levels below 3.0 mEq/L
- Potassium levels between 2.0 and 3.0 correspond to 400-800 mEq deficit.
- It may require intravenous supplementation. Typically, saline is used, with 20-40 mEq KCl per liter over 3-4 hours (ie, at an infusion rate of 10 mEq/L/h)
- Giving IV potassium at faster rates may predispose to ventricular tachycardias and requires intensive ECG monitoring.
- Giving IV KCl at doses >60 mEq/L are painful and can cause venous necrosis.
- Difficult or resistant cases of hypokalemia may be amenable to amiloride, a potassium-sparing diuretic, or spironolactone.
- When replacing potassium intravenously, infusion via central line is encouraged to avoid the frequent occurrence of a burning sensation at the site of a peripheral IV and the aforementioned venous necrosis. When peripheral infusions are necessary, the burning can be reduced by diluting the potassium in larger amounts of IV fluid, or mixing 3 ml of 1% lidocaine to each 10 meq of KCl per 50 ml of IV fluid. The practice of adding lidocaine, however, raises the likelihood of serious medical errors.[1]
- Potassium infusions via a central line can reach 200 mEq/L (20 mEq in 100 mL of isotonic saline) but the administration rate should not be greater than 10–20 mEq per hour.
- Saline solutions are preferred to prevent potassium transcellular shifting that is triggered by dextrose-induced insulin release.
References
- ↑ "Safety Issues With Adding Lidocaine to IV Potassium Infustions (Excerpt)". Retrieved 2013-02-27.